September: Blood Cancer Awareness Month

There are three major types of blood cancer: leukemia, lymphoma and multiple myeloma.

Blood cancer is rare and hard to diagnose. This is why many patients are left untreated during early stages of the disease. Symptoms may include: chest pain, fever, frequent infections and overall weakness.

Yearly, about 1 000 000 people worldwide are diagnosed with blood cancer.

Global Clinical Trials has successfully conducted several Phase II and Phase III studies in Lymphoma, and is familiar with the challenges blood cancer poses. We would like to use this opportunity to spread awareness about this group of diseases, and we hope that the diagnosis and treatments methods become more effective and precise very soon.

 

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.